ImpactFactor recently completed a study on supply-chain risk, surveying managers of more than 100 companies. The results were not encouraging. According to managing director Bill McBeath, many companies don't consider proactive risk-management to be a strategic tool. He was "shocked" at how level their level of investment in that area was, with half reporting expenditures of $50,000 or less to audit and assess suppliers. "Not a single one spent more than $3m," he says. "Given the huge potential impact [of risk] on their shares, we believe companies are seriously under-investing."
An increase in the number of suppliers, customers, carriers and countries is changing the importance of collaborative synchronization between all parties in the multi-tiered global supply chain.
Analyst Insight: Signing a contract and getting the business ramped up is just the beginning of an outsourcing deal. The real work is shaping the relationship and making the parties operate not only as a high-performance team, but also to allow the companies to embrace the dynamic nature of business and keep the parties aligned as "business happens." It's essential to have a flexible and cooperative governance framework. - Kate Vitasek, faculty of the University of Tennessee's Center for Executive Education, and founder, Supply Chain Visions
Analyst Insight: Recently, Big Pharma went through a significant period of mergers and acquisitions to gain a global market presence and product offering expansion. Now it appears the tides may be shifting. A segment of Big Pharma is shedding non-core business units and focusing on core profitability. But the acquisition strategy is not dead. These diverging paths are both focused on increasing flexibility and profitability to adapt to market uncertainty. Supply chain planning and adaptability have moved forward as integration of business units has increased in all regions of the globe. - Brian Hudock, partner, Tompkins International